Company page

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a public company traded under the ticker MIRM in the American market. The company has a market capitalization of approximately $6.89 billion. Mirum focuses on developing innovative therapies for rare diseases, aiming to address unmet medical needs.

MIRM:NASDAQUpdated August 28, 2026
Mirum Pharmaceuticals, Inc. logo
Ticker
MIRM:NASDAQ
Asset type
Stock
Market cap
$6.33B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD